Research!America

By Peter W. Kalivas, PhD, President of the American College of Neuropsychopharmacology. Dr. Kalivas is Professor and Chair, Department of Neurosciences at the Medical University of South Carolina. 


From KIYATEC website

Dear Research Advocate:

By Margaret Foti, PhD, MD (h.c.), Chief Executive Officer, American Association for Cancer Research

Dear Research Advocate:

Letter to the editor by Research!America VP of Communications Suzanne Ffolkes published in The New York Times in response to article, ’€œLabs Are Told to Start Including a Neglected Variable: Females’€ (May 14, 2014)

Election season is all about voters getting to know the candidates running for public office in their state.  Through town hall and other meetings, articles and editorials, advertisements and debates, voters obtain information about each candidate that can inform their decision-making at the polls.

Dear Research Advocate:

Congress continues to pay particular attention to – and make decisions bearing on – the pace of medical progress. To briefly count the ways:

The Senate Labor-HHS Appropriations subcommittee heard testimony yesterday from agency heads within HHS about the significance of health-related spending, including spending on medical and health research. Read our written testimony here.

medprRemember that all day tomorrow, Tuesday May 6, is a social media Day of Action in conjunction with the Medical Progress NOW campaign.

By Ellen L. Woods, President of the American Foundation for Pharmaceutical Education

Pages

Subscribe to RSS - Research!America